[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.238.28. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
March 3, 1999

Hormone Replacement Therapy for Secondary Prevention of Coronary Heart Disease

Author Affiliations
 

Margaret A.WinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor

JAMA. 1999;281(9):794-797. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-9-jbk0303

To the Editor: In HERS,1 there was an increase in the risk of CHD events associated with the use of HRT compared with placebo during the first year of follow-up, but in subsequent years, the risk was lower in women receiving HRT than placebo. In the accompanying Editorial, Dr Petitti2 cites our findings for duration of HRT use3 and suggests that these observational findings on duration of use contradict the clinical trial findings on recency of starting HRT. There are important differences between recency and duration.

First Page Preview View Large
First page PDF preview
First page PDF preview
×